PROPHYLACTIC NAPROXEN OR LORATADINE FOR BONE PAIN IN PATIENTS WITH BREAST CANCER RECEIVING CHEMOTHERAPY AND PEGFILGRASTIM: A RANDOMIZED, PHASE 2 STUDY (NOLAN) AMGEN 20110147; NCT 01712009.

被引:0
|
作者
Guinigundo, Andrew S. [1 ]
Maxwell, Cathy [2 ]
Vanni, Linda [3 ]
Watson, Holly [4 ]
Badre, Sejal [5 ]
Kirshner, Jeffrey J. [6 ]
机构
[1] Oncol Hematol Care Inc, Cincinnati, OH USA
[2] Adv Med Specialties, Miami, FL USA
[3] Providence Hosp, Southfield, MI 48037 USA
[4] Amgen Inc, Global Dev, Thousand Oaks, CA 91320 USA
[5] Amgen Inc, Global Biostat Sci, Thousand Oaks, CA 91320 USA
[6] Hematol Oncol Associates Cent New York, East Syracuse, NY USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:E429 / E429
页数:1
相关论文
共 50 条
  • [1] NOLAN: a randomized, phase 2 study to estimate the effect of prophylactic naproxen or loratadine vs no prophylactic treatment on bone pain in patients with early-stage breast cancer receiving chemotherapy and pegfilgrastim
    Jeffrey J. Kirshner
    Maxwell C. McDonald
    Flavio Kruter
    Andrew S. Guinigundo
    Linda Vanni
    Cathy L. Maxwell
    Maureen Reiner
    Terry E. Upchurch
    Jacob Garcia
    Phuong Khanh Morrow
    Supportive Care in Cancer, 2018, 26 : 1323 - 1334
  • [2] NOLAN: a randomized, phase 2 study to estimate the effect of prophylactic naproxen or loratadine vs no prophylactic treatment on bone pain in patients with early-stage breast cancer receiving chemotherapy and pegfilgrastim
    Kirshner, Jeffrey J.
    McDonald, Maxwell C., III
    Kruter, Flavio
    Guinigundo, Andrew S.
    Vanni, Linda
    Maxwell, Cathy L.
    Reiner, Maureen
    Upchurch, Terry E.
    Garcia, Jacob
    Morrow, Phuong Khanh
    SUPPORTIVE CARE IN CANCER, 2018, 26 (04) : 1323 - 1334
  • [3] Nolan: A randomized, phase II study to estimate the effect of prophylactic naproxen (N) or loratadine (L) vs no intervention on bone pain in 600 patients (pts) with early-stage breast cancer receiving chemotherapy (chemo) and pegfilgrastim (PEG).
    Kirshner, Jeffrey J.
    Guinigundo, Andrew S.
    Vanni, Linda
    Maxwell, Cathy L.
    Reiner, Maureen
    Garcia, Jacob
    Morrow, Phuong Khanh H.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [4] THE EFFECT OF PATIENT EDUCATION ON REPORTED BONE PAIN IN PATIENTS WITH BREAST CANCER RECEIVING CHEMOTHERAPY AND PEGFILGRASTIM: A RANDOMIZED, SINGLE-BLIND STUDY (VINE) AMGEN 20110148; NCT 01752907
    Vanni, Linda
    Maxwell, Cathy
    Guinigundo, Andrew
    Badre, Sejal
    Watson, Holly
    ONCOLOGY NURSING FORUM, 2013, 40 (06) : E438 - E439
  • [5] A Randomized, Single-Blind Study Evaluating the Effect of a Bone Pain Education Video on Reported Bone Pain in Patients with Breast Cancer Receiving Chemotherapy and Pegfilgrastim
    Guinigundo, Andrew S.
    Maxwell, Cathy L.
    Vanni, Linda
    Morrow, Phuong Khanh
    Reiner, Maureen
    Shih, Alex
    Klippel, Zandra
    Blanchard, Elizabeth
    PAIN MANAGEMENT NURSING, 2018, 19 (06) : 693 - 706
  • [6] A MULTICENTER RANDOMIZED PHASE III STUDY OF KRN125 (PEGFILGRASTIM) IN BREAST CANCER PATIENTS RECEIVING TC CHEMOTHERAPY
    Rai, Y.
    Sagara, Y.
    Kuranami, M.
    Masuda, N.
    Takano, T.
    Saeki, T.
    Nakamura, S.
    Ito, Y.
    Tokuda, Y.
    Tamura, K.
    ANNALS OF ONCOLOGY, 2013, 24 : 13 - 13
  • [7] A Phase III Randomized Equivalence Study of Biosimilar Filgrastim versus Amgen Filgrastim in Patients Receiving Myelosuppressive Chemotherapy for Breast Cancer
    Waller, Cornelius F.
    Semiglazov, Vladimir F.
    Tjulandin, Sergei
    Bentsion, Dmitry
    Chan, Stephen
    Challand, Rodeina
    ONKOLOGIE, 2010, 33 (10): : 504 - 511
  • [8] Reported Bone Pain in Patients with Breast Cancer Receiving Taxane-Based Chemotherapy in Clinical Trials of Pegfilgrastim
    Schwartzberg, L. S.
    Mo, M.
    Harms, R.
    Vogel, C. L.
    CANCER RESEARCH, 2009, 69 (24) : 576S - 576S
  • [9] A Phase III Study of Balugrastim Versus Pegfilgrastim in Breast Cancer Patients Receiving Chemotherapy With Doxorubicin and Docetaxel
    Gladkov, Oleg
    Moiseyenko, Vladimir
    Bondarenko, Igor N.
    Shparyk, Yaroslav
    Barash, Steve
    Adar, Liat
    Avisar, Noa
    ONCOLOGIST, 2016, 21 (01): : 7 - 15
  • [10] The effect of bone pain specific education vs general chemotherapy side -effect education on reported bone pain in patients (pts) with breast cancer receiving chemotherapy and pegfilgrastim
    Maxwell, C. L.
    Guinigundo, A. S.
    Vanni, L.
    Morrow, P. K.
    Reiner, M.
    Shih, A.
    Klippel, Z.
    Blanchard, E.
    CANCER RESEARCH, 2016, 76